Nov 14, 2018
Fervent Pharmaceuticals Completes Clinical Trial For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms
Oct 02, 2018
Ernest Mario, PhD joins Board of Representatives at Fervent Pharmaceuticals
Sep 27, 2018
Life Extension Further Promotes Women's Health Initiative With Launch Of Menopause 731(TM)
Sep 19, 2018
Global Hot Flashes Market Insights, Epidemiology and Market Forecast to 2027
Sep 04, 2018
Menopause Awareness Month News
Jul 20, 2018
Women's Excellence Offers Treatment Options for Women Suffering from Hot Flashes During the Summer Months
Jun 21, 2018
Menopause Makeover Founder, Staness Jonekos, Stresses Alternatives to Prescription Drugs for Menopausal Symptoms
May 30, 2018
TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY(TM) (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, due to Menopause
May 03, 2018
MenoGeniX Awarded NIH Grant to Fund Phase Ib/IIa Clinical Trial
Apr 17, 2018
Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms
Jan 10, 2018
Women's Health Market is Expected to Rise at a CAGR of 5.7% During 2017 to 2025, Globally: Transparency Market Research
Dec 28, 2017
New Menopause Therapy from Fervent Pharmaceuticals to Begin Clinical Trial
Oct 30, 2017
NEW to the United States: Equelle®, a Non-Hormonal Supplement Clinically Shown to Help Ease Menopause Symptoms*
Sep 27, 2017
KaNDy Therapeutics Launched to Advance a Breakthrough Treatment in Women's Health